Pharma
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign, making lobbying a challenge in 2025.
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign, making lobbying a challenge in 2025.
Become a Political Insider
Sign up for Today's Headlines newsletter now
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Before the campaign, Ottawa secured agreements with only four jurisdictions: Manitoba, British Columbia, Yukon, and Prince Edward Island.
- Before the campaign, Ottawa secured agreements with only four jurisdictions: Manitoba, British Columbia, Yukon, and Prince Edward Island.
- Before the campaign, Ottawa secured agreements with only four jurisdictions: Manitoba, British Columbia, Yukon, and Prince Edward Island.
- Health Minister Kamal Khera highlighted Yukon signing onto the pharmacare deal since Mark Carney became prime minister, saying the Liberal government 'will continue to
- Health Minister Kamal Khera highlighted Yukon signing onto the pharmacare deal since Mark Carney became prime minister, saying the Liberal government 'will continue to
- Health Minister Kamal Khera highlighted Yukon signing onto the pharmacare deal since Mark Carney became prime minister, saying the Liberal government 'will continue to
- Patients in Canada wait longer than most of our peer countries to access fewer medicines.
- Patients in Canada wait longer than most of our peer countries to access fewer medicines.
- Patients in Canada wait longer than most of our peer countries to access fewer medicines.
- The clock is 'loudly ticking' on a likely federal election in the spring, and it's important pharmacare deals are signed with the provinces and
- The clock is 'loudly ticking' on a likely federal election in the spring, and it's important pharmacare deals are signed with the provinces and
- The clock is 'loudly ticking' on a likely federal election in the spring, and it's important pharmacare deals are signed with the provinces and
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.